Literature DB >> 21414403

The molecular basis of aminoacylase 1 deficiency.

Anke Sommer1, Ernst Christensen, Susanne Schwenger, Ralf Seul, Dorothea Haas, Heike Olbrich, Heymut Omran, Jörn Oliver Sass.   

Abstract

Aminoacylase 1 is a zinc-binding enzyme which hydrolyzes N-acetyl amino acids into the free amino acid and acetic acid. Deficiency of aminoacylase 1 due to mutations in the aminoacylase 1 (ACY1) gene follows an autosomal-recessive trait of inheritance and is characterized by accumulation of N-acetyl amino acids in the urine. In affected individuals neurological findings such as febrile seizures, delay of psychomotor development and moderate mental retardation have been reported. Except for one missense mutation which has been studied in Escherichia coli, mutations underlying aminoacylase 1 deficiency have not been characterized so far. This has prompted us to approach expression studies of all mutations known to occur in aminoacylase 1 deficient individuals in a human cell line (HEK293), thus providing the authentic human machinery for posttranslational modifications. Mutations were inserted using site directed mutagenesis and aminoacylase 1 enzyme activity was assessed in cells overexpressing aminoacylase 1, using mainly the natural high affinity substrate N-acetyl methionine. Overexpression of the wild type enzyme in HEK293 cells resulted in an approximately 50-fold increase of the aminoacylase 1 activity of homogenized cells. Most mutations resulted in a nearly complete loss of enzyme function. Notably, the two newly discovered mutations p.Arg378Trp, p.Arg378Gln and the mutation p.Arg393His yielded considerable residual activity of the enzyme, which is tentatively explained by their intramolecular localization and molecular characteristics. In contrast to aminoacylase 1 variants which showed no detectable aminoacylase 1 activity, aminoacylase 1 proteins with the mutations p.Arg378Trp, p.Arg378Gln and p.Arg393His were also detected in Western blot analysis. Investigations of the molecular bases of additional cases of aminoacylase 1 deficiency contribute to a better understanding of this inborn error of metabolism whose clinical significance and long-term consequences remain to be elucidated. 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21414403     DOI: 10.1016/j.bbadis.2011.03.005

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

1.  Acylpeptide hydrolase (APEH) sequence variants with potential impact on the metabolism of the antiepileptic drug valproic acid.

Authors:  Despina Tsortouktzidis; Kathleen Grundke; Claudia Till; Anne Korwitz-Reichelt; Jörn Oliver Sass
Journal:  Metab Brain Dis       Date:  2019-07-30       Impact factor: 3.584

2.  Metabolic cycles in a circannual hibernator.

Authors:  L Elaine Epperson; Anis Karimpour-Fard; Lawrence E Hunter; Sandra L Martin
Journal:  Physiol Genomics       Date:  2011-05-03       Impact factor: 3.107

3.  Expanding the phenotype in aminoacylase 1 (ACY1) deficiency: characterization of the molecular defect in a 63-year-old woman with generalized dystonia.

Authors:  Jörn Oliver Sass; Jathana Vaithilingam; Corinne Gemperle-Britschgi; Cathérine C S Delnooz; Leo A J Kluijtmans; Bart P C van de Warrenburg; Ron A Wevers
Journal:  Metab Brain Dis       Date:  2015-12-19       Impact factor: 3.584

4.  Study of the expression and function of ACY1 in patients with colorectal cancer.

Authors:  Bing Yu; Xuezhong Liu; Xiuzhen Cao; Mingyue Zhang; Hong Chang
Journal:  Oncol Lett       Date:  2017-02-08       Impact factor: 2.967

5.  Isolated mild intellectual disability expands the aminoacylase 1 phenotype spectrum.

Authors:  Maria G Alessandrì; Manuela Casarano; Ilaria Pezzini; Stefano Doccini; Claudia Nesti; Giovanni Cioni; Roberta Battini
Journal:  JIMD Rep       Date:  2014-07-06

6.  A comprehensive clinical and genetic study in 127 patients with ID in Kinshasa, DR Congo.

Authors:  Aimé Lumaka; Valerie Race; Hilde Peeters; Anniek Corveleyn; Zeynep Coban-Akdemir; Shalini N Jhangiani; Xiaofei Song; Gerrye Mubungu; Jennifer Posey; James R Lupski; Joris R Vermeesch; Prosper Lukusa; Koenraad Devriendt
Journal:  Am J Med Genet A       Date:  2018-08-08       Impact factor: 2.802

7.  Natural human genetic variation determines basal and inducible expression of PM20D1, an obesity-associated gene.

Authors:  Kiara K Benson; Wenxiang Hu; Angela H Weller; Alexis H Bennett; Eric R Chen; Sumeet A Khetarpal; Satoshi Yoshino; William P Bone; Lin Wang; Joshua D Rabinowitz; Benjamin F Voight; Raymond E Soccio
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-28       Impact factor: 11.205

8.  Plasma metabolites to profile pathways in noncommunicable disease multimorbidity.

Authors:  Maik Pietzner; Isobel D Stewart; Johannes Raffler; Kay-Tee Khaw; Gregory A Michelotti; Gabi Kastenmüller; Nicholas J Wareham; Claudia Langenberg
Journal:  Nat Med       Date:  2021-03-11       Impact factor: 53.440

9.  Proteomic profiling reveals biomarkers and pathways in type 2 diabetes risk.

Authors:  Debby Ngo; Mark D Benson; Jonathan Z Long; Zsu-Zsu Chen; Ruiqi Wang; Anjali K Nath; Michelle J Keyes; Dongxiao Shen; Sumita Sinha; Eric Kuhn; Jordan E Morningstar; Xu Shi; Bennet D Peterson; Christopher Chan; Daniel H Katz; Usman A Tahir; Laurie A Farrell; Olle Melander; Jonathan D Mosley; Steven A Carr; Ramachandran S Vasan; Martin G Larson; J Gustav Smith; Thomas J Wang; Qiong Yang; Robert E Gerszten
Journal:  JCI Insight       Date:  2021-03-08

10.  Serum aminoacylase-1 is a novel biomarker with potential prognostic utility for long-term outcome in patients with delayed graft function following renal transplantation.

Authors:  Matthew P Welberry Smith; Alexandre Zougman; David A Cairns; Michelle Wilson; Tobias Wind; Steven L Wood; Douglas Thompson; Michael P Messenger; Andrew Mooney; Peter J Selby; Andrew J P Lewington; Rosamonde E Banks
Journal:  Kidney Int       Date:  2013-06-05       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.